Investor
Presentation
Rainbow Global Manufacturing
Base
Subsidiary /
Office R&D Centers
Weifang, Qingdao, Ningxia 8600+ Registrations Globally
Manufacturing Bases
Spain Manufacturing Base
Jinan Office
U.S. Houston, Champaign
Manufacturing Bases
Weifang, Jinan R&D Centers
Weifang Process Development Center
Industry Overview
Export Volume Trends of Products Under China HS Code 3808
• Q1-Q3 2025: Total export volume increased by 20.91% YoY.
• Q3 2025: Total export volume increased by 28.69% YoY.
* HS: Harmonized System
Industry Overview
Export Value Trends of Products Under China HS Code 3808
Hundred
Million 2025 2024 2023 2022
USD
Hundred 1 2 3 4 5 6 7 8 9 10 11 12
Million
USD
• Q1-Q3 2025: Total export value increases by 16.48% YoY.
• Q3 2025: Total export value increased by 21.61% YoY.
* HS: Harmonized System
Industry Overview
Export Unit Price Trends of Products Under China HS Code 3808
USD/Kg
USD/Kg 11 22 33 44 55 66 77 88 99 1010 1111 12 12
• Q1-Q3 2025: Monthly average export unit price decreased from $ 2.87/kg in
January to $ 2.96/kg in September.
* HS: Harmonized System
Q3 2025 Operational Review
Operational Increased To C Business Increased EU & NA Business
Review of Our TO C revenue rose from 37.73% in the first
three quarters of 2024 to 41.39% in the
EU & North American operations increased
from 8.53% in the first three quarters of
Four Strategic same period of 2025, while gross margin
improved from 29.37% to 30.88%.
Growth Pillars
Increased Insecticide & Fungicide Rainbow Bio Business
Business Acceleration
Insecticide & fungicide revenue increased Rainbow Bio has expanded operations
from 25.46% in the first three quarters of across new markets in Africa, Asia, and the
* EU: European Union
* NA: North American
Financial Highlights
Q1-Q3 2025 Financial Performance Analysis (YoY) Unit: RMB (¥)
Currency
Q1-Q3 2025 Q1-Q3 2024 %▲ Note
RMB
Sales Revenue
Stable growth across all business
segments.
YoY gross margin rate
Gross Margin(%) 22.08% 20.36% 172bps improvement for both Model A/B
and Model C businesses.
Higher gross margin rate drives
EBITDA 1,409,677,857.04 1,214,482,864.94 16.07%
YoY EBITDA growth.
EBITDA Profit(%) 12.92% 12.41% 51bps
• Revenue growth with gross
Net Profit Attributable to the margin rate enhancement.
Owner of Parent 889,733,619.13 341,563,969.19 160.49%
• Increased financial expenses
& hedging gains.
Net Operating Cash Flow 1,740,314,337.78 459,081,421.38 279.09% Improved payment collection.
Financial Highlights
Q1-Q3 2025 Financial Performance Analysis (YoY) Unit: RMB (¥)
Currency
Q1-Q3 2025 Q1-Q3 2024 %▲ Note
RMB
Higher sales expenses mainly
stemmed from increased
Selling & Distribution
Expenses 541,276,149.24 423,513,169.91 27.81% overseas payroll, export credit
insurance and professional
service fees.
Mainly from higher overseas
General & Administrative
Expenses 401,415,429.92 347,669,755.50 15.46% payroll and
depreciation/amortization.
Primarily due to increased R&D
R&D Expenses 133,772,534.32 125,724,753.40 6.40% investment.
Financial Highlights
Q3 2025 Financial Performance Analysis (YoY) Unit: RMB (¥)
Currency
Q3 2025 Q3 2024 %▲ Note
RMB
Sales Revenue Stable growth across all business
YoY gross margin rate
Gross Margin(%) 23.08% 20.56% 252bps improvement for both Model A/B
and Model C businesses.
Higher gross margin rate drives
EBITDA 594,267,382.45 514,247,915.29 15.56%
YoY EBITDA growth.
EBITDA Profit(%) 13.57% 12.53% 104bps
Net Profit Attributable to the Revenue growth with gross margin
Owner of Parent 334,130,258.84 159,769,717.17 109.13%
rate enhancement.
Net Operating Cash Flow 847,132,095.62 597,832,636.16 41.70% Improved payment collection.
Financial Highlights
Q3 2025 Financial Performance Analysis (YoY) Unit: RMB (¥)
Currency
Q3 2025 Q3 2024 %▲ Note
RMB
Higher sales expenses mainly
Selling & Distribution stemmed from increased
Expenses 200,431,556.18 155,794,042.76 28.65% overseas payroll and export
credit insurance.
Primarily due to increased
General & Administrative
Expenses 148,272,592.23 135,257,536.76 9.62% depreciation/amortization and IT
expenses during the period.
R&D Expenses 50,344,221.33 53,882,633.26 -6.57%
Financial Highlights
Q1-Q3 2025 Revenue Status by Geographic Segment
Q1-Q3 2025 Revenue:
Q1-Q3 Brazil
Latin North
Europe
Middle
Asia (China Oceania
America America East/Africa
inclusive)
Q1-Q3 Brazil
Latin North
Europe
Middle Asia (China Oceania
America America East/Africa inclusive)
Financial Highlights
Quarterly EBITDA & EBITDA% Comparison
EBITDA EBITDA%
- .00 0.00%
Hundred Q1 Q2 Q3 Q1-Q3 Q1 Q2 Q3 Q1-Q3
Million
Financial Highlights
Revenue Share by Segment (YoY)
Revenue by Segment (Q1-Q3) Quarterly Revenue by Segment
Mode C Mode A + Mode C Mode A + Mode C Mode A + Mode C Mode A + Mode C Mode A +
Q1-Q3 2024 Q1-Q3 2025 Q3 2024 Q2 2025 Q3 2025
Financial Highlights
Gross Margin Rate Comparison by Segment
Gross Margin Rate by Segment (Q1-Q3) Quarterly Gross Margin Rate by Segment
Mode A + Mode B Mode C Mode A + Mode B Mode C
Q1-Q3 2024 Q1-Q3 2025 Q3 2024 Q2 2025 Q3 2025
Financial Highlights
Revenue by Product Category
Revenue by Product Category (Q1-Q3) Quarterly Revenue by Product Category
Other Other Fungicide
Fungicide Fungicide 1.36% Other Fungicide Other Fungicide Other
Insecticide Insecticide
Herbicide 18.43% Herbicide Herbicide 16.10% Herbicide 21.67% Herbicide
Q1-Q3 2024 Q1-Q3 2025 Q3 2024 Q2 2025 Q3 2025
Financial Highlights
Gross Margin Rate Comparison by Product Category
Gross Margin Rate by Product Category (Q1-Q3) Quarterly Gross Margin Rate by Product Category
Herbicide Insecticide Fungicide Herbicide Insecticide Fungicide
Q1-Q3 2024 Q1-Q3 2025 Q3 2024 Q2 2025 Q3 2025
To be a Global Leading Crop
Protection Company
THANK YOU